Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma.

ABSTRACT:

Background & aims

Direct-acting antivirals (DAAs) are effective against hepatitis C virus and sustained virologic response is associated with reduced incidence of hepatocellular carcinoma (HCC). However, there is controversy over the use of DAAs in patients with active or treated HCC and uncertainty about optimal management of these patients. We aimed to characterize attitudes and practice patterns of hepatology practitioners in the United States regarding the use of DAAs in patients with HCC.

Methods

We conducted a survey of hepatology providers at 47 tertiary care centers in 25 states. Surveys were sent to 476 providers and we received 279 responses (58.6%).

Results

Provider beliefs about risk of HCC recurrence after DAA therapy varied: 48% responded that DAAs reduc

SUBMITTER: Rich NE 

PROVIDER: S-EPMC8174017 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature